LOGIN TO YOUR ACCOUNT

Username
Password
Remember Me
Or use your Academic/Social account:

CREATE AN ACCOUNT

Or use your Academic/Social account:

Congratulations!

You have just completed your registration at OpenAire.

Before you can login to the site, you will need to activate your account. An e-mail will be sent to you with the proper instructions.

Important!

Please note that this site is currently undergoing Beta testing.
Any new content you create is not guaranteed to be present to the final version of the site upon release.

Thank you for your patience,
OpenAire Dev Team.

Close This Message

CREATE AN ACCOUNT

Name:
Username:
Password:
Verify Password:
E-mail:
Verify E-mail:
*All Fields Are Required.
Please Verify You Are Human:
fbtwitterlinkedinvimeoflicker grey 14rssslideshare1
Asare-Addo, Kofi; Conway, Barbara R; Larhrib, Hassan; Levina, Marina; Rajabi-Siahboomi, Ali R.; Tetteh, John; Boateng, Joshua; Nokhodchi, Ali (2013)
Publisher: Elsevier
Languages: English
Types: Article
Subjects: Q1
The evaluation of the effects of different media ionic strengths and pH on the release of hydrochlorothiazide, a poorly soluble drug, and diltiazem hydrochloride, a cationic and soluble drug, from a gel forming hydrophilic polymeric matrix were the objectives of this study. The drug to polymer ratio of formulated tablets was 4:1. Hydrochlorothiazide or diltiazem HCl extended release (ER) matrices containing hypromellose (hydroxypropyl methylcellulose (HPMC)) were evaluated in media with a pH range of 1.2-7.5, using an automated USP type III, Bio-Dis dissolution apparatus. The ionic strength of the media was varied over a range of 0-0.4 M to simulate the gastrointestinal fed and fasted states and various physiological pH conditions. Sodium chloride was used for ionic regulation due to its ability to salt out polymers in the midrange of the lyotropic series. The results showed that the ionic strength had a profound effect on the drug release from the diltiazem HCl K100LV matrices. The K4M, K15M and K100M tablets however withstood the effects of media ionic strength and showed a decrease in drug release to occur with an increase in ionic strength. For example, drug release after the 1 hr mark for the K100M matrices in water was 36 %. Drug release in pH 1.2 after 1 hr was 30 %. An increase of the pH 1.2 ionic strength to 0.4 M saw a reduction of drug release to 26 %. This was the general trend for the K4M and K15M matrices as well. The similarity factor f2 was calculated using drug release in water as a reference. Despite similarity occurring for all the diltiazem HCl matrices in the pH 1.2 media (f2=64-72), increases of ionic strength at 0.2 M and 0.4 M brought about dissimilarity. The hydrochlorothiazide tablet matrices showed similarity at all the ionic strength tested for all polymers (f2= 56-81). The values of f2 however reduced with increasing ionic strengths. DSC hydration results explained the hydrochlorothiazide release from their HPMC matrices. There was an increase in bound water as ionic strengths increased. Texture analysis was employed to determine the gel strength and also to explain the drug release for the diltiazem hydrochloride. This methodology can be used as a valuable tool for predicting potential ionic effects related to in vivo fed and fasted states on drug release from hydrophilic ER matrices.\ud Keywords: Ionic strength, HPMC polymeric matrix tablets, Similarity factor, Kinetics of drug release, Hydration, Diltiazem HCl, Hydrochlorothiazide.
  • The results below are discovered through our pilot algorithms. Let us know how we are doing!

    • [1] B. Sasa, P. Odon, S. Stane, and K. Julijana, Eur. J. Pharm. Sci. 27 (2006) 375-383.
    • [2] C. G. Wilson, N. Washington, in Physiological Pharmaceutics, Chichester: Ellis Horwood Ltd, (1989) 47-68.
    • [3] W. N. Charman, C. J. H. Porter, S. Mithani, J. B. Dressman, J. Pharm. Sci. 86 (1997) 269-282.
    • [4] J. L. Johnson, J. Holinej, M. D. Williams, Int. J. Pharm. 90 (1993) 151-159.
    • [5] M. C. Bonferoni, S. Rossi, F. Ferrari, M. Bertoni, C. Caramella, Int. J. Pharm. 117 (1995) 41-48.
    • [6] A. C. Hodsdon, J. R. Mitchell, M. C. Davies, C. D. Melia, J. Control Release 33 (1995) 143-152.
    • [7] A. Lindahl, A. L. Ungell, L. Knutson, H. Lennernas, Pharm Res 14 (1997) 497-502.
    • [8] K. Mitchell, J.L. Ford, D.J. Armstrong, P.N.C. Elliott, C. Rostron, J.E. Hogan, Int. J. Pharm. 66 (1990) 233-242.
    • [9] M. S. Jhon, J. D. Andrade, J Biomed Mater Res 7 (1973) 509-522.
    • [10] S. Aoki, H. Ando, M. Ishii, S. Watanabe, H. Ozawa. J Control Release 33 (1995) 365- 374.
    • [11] S. Yoshioka, Y. Aso, T. Terao. Pharm Res 9 (1992) 607-612.
    • [12] S. Baumgartner, G. Lahajnar, A. Sepe, J. Kristl Investigation of the state and dynamics of water in hydrogels of cellulose ethers by 1H NMR spectroscopy. AAPS PharmSciTech 3 (2002) E36.
    • [13] K. Asare-Addo, M. Levina, A.R. Rajabi-Siahboomi, A. Nokhodchi, Carbohydrate Polym. 86 (2011) 85-93.
    • [14] K. Asare-Addo, M. Levina, A.R. Rajabi-Siahboomi, A. Nokhodchi, Colloids Surf. B: Biointerf. 81 (2010) 452-460.
    • [15] K. Asare-Addo, W. Kaialy, M. Levina, A.R. Rajabi-Siahboomi, M. U. Ghori, E. Supuk, P. R. Laity, B. R. Conway, A. Nokhodchi, Colloids Surf. B: Biointerf. 104 (2013) 54-60.
    • [16] J. W. Moore, H. H. Flanner, Pharm Technol 20 (1996) 64-74.
    • [17] J.E. Polli, G.S. Rekhi, L.L. Augsburger, V.P. Shah, J. Pharm. Sci. 86 (1997) 690-700.
    • [18] T. Durig, R. Fassihi, J Control Release 67 (2000) 37-44.
    • [19] L.S.C. Wan, P.W.S. Heng, L.F. Wong, Int. J. Pharm. 116 (1995) 159-168.
    • [20] J. Siepmann, N. A. Peppas, Adv. Drug Deliv. Rev. 48 (2001) 139-157.
    • [21] M.C. Bonferoni, S. Rossi, F. Ferrari, E. Stavik, A. Pena-Romero, C. Caramella, AAPS Pharm. Sci. Tech. 1 (2) (2000). article 15.
    • [22] K. Mitchell, J.L. Ford, D.J. Armstrong, P.N.C. Elliott, J.E. Hogan, C. Rostron, Int J Pharm 100 (1993)165-173.
    • [23] M.F. Tutunji, H.M. Ibrahim, M.H. Khabbas, L.F. Tutunji, J Chromotogr B. 877 (2009) 1689-1697.
    • [24] N. Kavanagh, O.I. Corrigan, Int. J. Pharm. 279 (2004) 141-152.
    • [25] D.A. Alderman, Int. J. Pharm. Technol. Prod. Manuf. 5 (1984) 1-9.
    • [26] I. Katzhendler, K. Mader, M. Friedman, Int. J. Pharm. 200 (2000) 161- 179.
  • No related research data.
  • No similar publications.

Share - Bookmark

Cite this article